JPMorgan Chase & Co. Buys 92,014 Shares of DaVita Inc. (NYSE:DVA)

JPMorgan Chase & Co. increased its stake in DaVita Inc. (NYSE:DVA) by 17.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 609,076 shares of the company’s stock after purchasing an additional 92,014 shares during the period. JPMorgan Chase & Co. owned approximately 0.74% of DaVita worth $99,846,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Transcendent Capital Group LLC acquired a new position in shares of DaVita in the 3rd quarter valued at approximately $25,000. Blue Trust Inc. raised its position in DaVita by 56.4% during the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after purchasing an additional 119 shares in the last quarter. Quarry LP bought a new stake in DaVita during the third quarter worth $60,000. Point72 Hong Kong Ltd acquired a new stake in shares of DaVita in the 2nd quarter valued at $68,000. Finally, ORG Wealth Partners LLC bought a new position in shares of DaVita in the 3rd quarter valued at $97,000. Institutional investors own 90.12% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on DVA. Truist Financial upped their price objective on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Barclays raised their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $161.80.

DaVita Stock Up 0.2 %

Shares of NYSE DVA opened at $149.82 on Friday. The company has a 50 day simple moving average of $155.19 and a 200 day simple moving average of $151.50. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. DaVita Inc. has a 1 year low of $103.40 and a 1 year high of $169.51. The firm has a market cap of $12.29 billion, a PE ratio of 16.16, a price-to-earnings-growth ratio of 0.86 and a beta of 0.90.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the business posted $2.85 EPS. DaVita’s revenue was up 4.6% on a year-over-year basis. On average, research analysts forecast that DaVita Inc. will post 9.71 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.